Private Advisor Group, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1567755 MORRISTOWN, NJ

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$527,752

+$101,409 QoQ

Shares Held

890

+1.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

3 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Derivatives in UTHR

reported options exposure · as of Sep 30, 2023

CallValue

$2,213,526

CallShares

9,800

PutValue

$993,828

PutShares

4,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Private Advisor Group, LLC holds $12,585,036 across 16 Drug Manufacturers - Specialty & Generic names. UTHR ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	185,024	$4,427,624
2	HLN	Haleon plc	219,187	$2,194,061
3	ZTS	Zoetis Inc.	15,150	$1,790,881
4	HIMS	Hims & Hers Health, Inc.	42,625	$884,895
5	TEVA	Teva Pharmaceutical Industries Ltd	21,888	$659,266
6	VTRS	Viatris Inc	41,557	$561,435
7	UTHR	UNITED THERAPEUTICS Corp This page	890	$527,752
8	TAK	Takeda Pharmaceutical Co Ltd	26,488	$490,557

All Filings in UTHR

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$527,752	890	+1.7%	Shares	Sole	2026-04-27
2025-12-31	$426,343	875	+717.8%	Shares	Sole	2026-02-17
2023-09-30	$24,168	107	-98.9%	Shares	Sole	2023-11-03
2023-09-30	$2,213,526	9,800	+122.7%	Call	Sole	2023-11-03
2023-09-30	$993,828	4,400	—	Put	Sole	2023-11-03
No filing history on record for this holder in this stock.